Mouse models of lupus: what they tell us and what they don’t is a research paper published in Lupus Science & Medicine (2018). On theSindex it has a DataRank of 0.789. It has been cited 191 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.789
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →FWCI
12.63
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Chronic exposure to PM2.5 aggravates SLE manifestations in lupus-prone mice
Additional file 1 of Chronic exposure to PM2.5 aggravates SLE manifestations in lupus-prone mice
Additional file 2 of Chronic exposure to PM2.5 aggravates SLE manifestations in lupus-prone mice
Additional file 2 of Chronic exposure to PM2.5 aggravates SLE manifestations in lupus-prone mice
Additional file 3 of Chronic exposure to PM2.5 aggravates SLE manifestations in lupus-prone mice
Additional file 3 of Chronic exposure to PM2.5 aggravates SLE manifestations in lupus-prone mice
Additional file 4 of Chronic exposure to PM2.5 aggravates SLE manifestations in lupus-prone mice
Additional file 4 of Chronic exposure to PM2.5 aggravates SLE manifestations in lupus-prone mice
Additional file 1 of Characterization of the mechanism of action of lanraplenib, a novel spleen tyrosine kinase inhibitor, in models of lupus nephritis
Additional file 1 of Characterization of the mechanism of action of lanraplenib, a novel spleen tyrosine kinase inhibitor, in models of lupus nephritis
Additional file 1 of Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
Additional file 1 of Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
Additional file 2 of Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
Additional file 3 of Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
Additional file 3 of Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
Additional file 2 of Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy